Skip to main content

Peer Review reports

From: Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

Original Submission
28 Feb 2018 Submitted Original manuscript
7 Aug 2018 Reviewed Reviewer Report - Sophie Ferlicot
19 Feb 2019 Reviewed Reviewer Report - Kwonoh Park
25 Feb 2019 Reviewed Reviewer Report - Yoon Ji Choi
26 Mar 2019 Author responded Author comments - Inkeun Park
Resubmission - Version 2
26 Mar 2019 Submitted Manuscript version 2
19 May 2019 Reviewed Reviewer Report - Sophie Ferlicot
29 May 2019 Author responded Author comments - Inkeun Park
Resubmission - Version 3
29 May 2019 Submitted Manuscript version 3
Publishing
31 May 2019 Editorially accepted
10 Jun 2019 Article published 10.1186/s12894-019-0484-2

You can find further information about peer review here.

Back to article page